Sponsor Pipeline

Fate Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07570862 A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis Lupus Nephritis Not Yet Recruiting
Phase 1
NCT06241456 FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in… Advanced Solid Tumor Recruiting
NCT07216105 FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With… Non-Small Cell Lung Cancer Recruiting
NCT06308978 A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV) Recruiting
NCT04629729 FT819 in Subjects With B-cell Malignancies Lymphoma, B-Cell Active, Not Recruiting
Disease Areas
Lupus (SLE) (2) Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1) Chronic Lymphocytic Leukemia (CLL) (1) Scleroderma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Colorectal Cancer (1) Ovarian Cancer (1)
Get alerts when Fate Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free